Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
TPG
Pharma
Cash-desperate Valeant talks $10B Salix deal with Takeda: WSJ
Earlier this year, Valeant reportedly turned down a takeover offer from Takeda and TPG. Now, the Japanese drugmaker wants to snag just one piece of the embattled company--and this time, Valeant may be happy to oblige.
Carly Helfand
Nov 1, 2016 10:14pm
Hepalink joins again with TPG on biotech fund
Jun 19, 2016 3:32pm
Valeant turned down Takeda-TPG takeover offer: WSJ
May 27, 2016 8:26am